Diagnostics
Sansure Biotech of Changsha raised $77M in a funding round led by Lilly Asia Ventures and Highlight Capital with participation from June Capital.
The listing of a minority of the unit, which makes X-ray and MRI machines, is set to take place in the first half of 2018.
The company announced the study in a blog post on its website.
Both companies are noted for growth through acquisition, and 2017 has been a very big year for LabCorp.
The military reviewed bids from 31 suitors and is good to Dec. 20, 2022.
Many people will be surprised to learn that Theranos is still open and doing business, let alone to be able to acquire a $100M loan.
The round was led by Berkshire Partners and TPG Growth, with participation from its co-founders and management team, as well as original investors Oak Investment Partners and J.H. Whitney.
Biotechs are taking notice as a new pool of funding is being made available by venture capital Andreesen Horowitz.
Four months after Jeff Huber stepped down as CEO of GRAIL, the company has tapped his replacement.
Kangmei will supply the JV with 95% of the $7.6M in cash, while BGI will contribute the remaining 5% of the JV’s value with instruments and technology.
PRESS RELEASES